Department of Emergency Medicine, Allegheny Health Network, Pittsburgh, PA.
Department of Emergency Medicine, Allegheny Health Network, Pittsburgh, PA.
Air Med J. 2022 Sep-Oct;41(5):451-457. doi: 10.1016/j.amj.2022.05.003. Epub 2022 Jun 18.
Hemodynamic instability and hemorrhagic shock are frequently encountered by emergency medical services providers managing ill and injured patients during critical care transport. Although many critical care transport services commonly transfuse crystalloids and/or packed red blood cells (PRBCs), the administration of whole blood (WB) in prehospital care is currently limited. WB contains PRBCs, plasma, and platelets in a physiologic ratio to aid in oxygen delivery to tissue as well as hemostasis. This study describes a single critical care transport program's experience using WB for critically ill and injured patients and reports important clinical and safety outcomes.
This study was a retrospective review of patients who were transported by a single rotor wing-based critical care transport service to 1 of 2 tertiary care receiving hospitals within a single health system. Patients who were transported between November 1, 2018, and November 30, 2019, and who received at least 1 unit of low-titer group O WB during critical care transport were included. The primary outcomes of interest included 24-hour mortality and the total 24-hour transfusion requirement. The safety outcomes included transfusion reactions, acute lung injury, acute kidney injury, and the incidence of venous thromboembolism.
During the study period, there were 3,084 total patients transported by our critical care transport service. There were 71 patients who received prehospital WB, 64 of whom met the inclusion criteria. The top 3 indications for WB administration included blunt trauma (n = 27, 42.2%), gastrointestinal hemorrhage (n = 15, 23.4%), and penetrating trauma (n = 11, 17.2%). The median total number of blood components transfused within 24 hours was 4.0 (interquartile range, 2.0-9.5), and the overall 24-hour mortality rate was 21.9%.
The administration of WB by emergency medical services providers to critically ill and injured patients in the prehospital setting is feasible and is associated with low incidences of adverse events and transfusion reactions. Further research is needed to elucidate the benefits of WB relative to current prehospital standards of care.
在危重症患者转运的急救医疗服务中,血流动力学不稳定和出血性休克是经常遇到的情况。尽管许多重症监护转运服务通常输注晶体液和/或浓缩红细胞(PRBC),但在院前急救中使用全血(WB)的情况目前受到限制。WB 中 PRBC、血浆和血小板以生理比例存在,有助于向组织输送氧气和止血。本研究描述了一个单一的重症监护转运项目使用 WB 治疗危重症和受伤患者的经验,并报告了重要的临床和安全结果。
这是一项对在单一卫生系统内的 2 家三级医院之间通过单旋翼直升机重症监护转运服务转运的患者进行的回顾性研究。纳入标准为在 2018 年 11 月 1 日至 2019 年 11 月 30 日期间转运且在重症监护转运期间至少输注了 1 单位低滴度 O 型 WB 的患者。主要关注的结局包括 24 小时死亡率和 24 小时总输血需求。安全性结局包括输血反应、急性肺损伤、急性肾损伤和静脉血栓栓塞症的发生率。
在研究期间,有 3084 名患者通过我们的重症监护转运服务转运。有 71 名患者在院前接受了 WB,其中 64 名符合纳入标准。WB 给药的前 3 大适应证包括钝性创伤(n=27,42.2%)、胃肠道出血(n=15,23.4%)和穿透性创伤(n=11,17.2%)。24 小时内输注的血液成分总数中位数为 4.0(四分位间距,2.0-9.5),24 小时总死亡率为 21.9%。
在院前环境中,急救医疗服务提供者向危重症和受伤患者给予 WB 是可行的,并且与不良事件和输血反应的发生率低有关。需要进一步的研究来阐明 WB 相对于当前院前标准护理的益处。